Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Abracl | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Abracl (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABRACL mRNA | CTD | PMID:22206623 | Abracl | Rat | 17beta-estradiol | decreases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Estradiol results in decreased expression of ABRACL mRNA | CTD | PMID:20106945 | Abracl | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ABRACL mRNA | CTD | PMID:20106945 more ... | Abracl | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ABRACL mRNA | CTD | PMID:34747641 | Abracl | Rat | 2-hydroxypropanoic acid | affects expression | ISO | ABRACL (Homo sapiens) | 6480464 | Lactic Acid affects the expression of ABRACL mRNA | CTD | PMID:30851411 | Abracl | Rat | 2-palmitoylglycerol | increases expression | ISO | ABRACL (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of ABRACL mRNA | CTD | PMID:37199045 | Abracl | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ABRACL (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABRACL mRNA | CTD | PMID:28628672 | Abracl | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ABRACL mRNA | CTD | PMID:28959563 | Abracl | Rat | aflatoxin B1 | affects expression | ISO | ABRACL (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of ABRACL protein | CTD | PMID:20106945 | Abracl | Rat | aflatoxin B1 | decreases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of ABRACL mRNA | CTD | PMID:22100608 | Abracl | Rat | aflatoxin B1 | increases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of ABRACL mRNA | CTD | PMID:21632981 | Abracl | Rat | all-trans-retinoic acid | increases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ABRACL mRNA | CTD | PMID:33167477 | Abracl | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of ABRACL mRNA | CTD | PMID:30047161 | Abracl | Rat | arsenite(3-) | multiple interactions | ISO | ABRACL (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to ABRACL mRNA] | CTD | PMID:32406909 | Abracl | Rat | benzo[a]pyrene | increases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of ABRACL mRNA | CTD | PMID:20106945 more ... | Abracl | Rat | benzo[a]pyrene | decreases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of ABRACL mRNA | CTD | PMID:32234424 | Abracl | Rat | benzo[a]pyrene | decreases methylation | ISO | ABRACL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ABRACL 5' UTR and Benzo(a)pyrene results in decreased methylation of ABRACL promoter | CTD | PMID:27901495 | Abracl | Rat | bisphenol A | increases expression | ISO | ABRACL (Homo sapiens) | 6480464 | bisphenol A results in increased expression of ABRACL mRNA | CTD | PMID:25047013 | Abracl | Rat | bisphenol A | decreases expression | ISO | ABRACL (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of ABRACL protein | CTD | PMID:37567409 | Abracl | Rat | bisphenol A | decreases methylation | ISO | ABRACL (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of ABRACL gene | CTD | PMID:31601247 | Abracl | Rat | bisphenol A | decreases expression | ISO | Abracl (Mus musculus) | 6480464 | bisphenol A results in decreased expression of ABRACL mRNA | CTD | PMID:33221593 | Abracl | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ABRACL mRNA | CTD | PMID:30816183 | Abracl | Rat | bisphenol A | multiple interactions | ISO | ABRACL (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABRACL mRNA | CTD | PMID:28628672 | Abracl | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ABRACL mRNA | CTD | PMID:25181051 | Abracl | Rat | carbamazepine | affects expression | ISO | ABRACL (Homo sapiens) | 6480464 | Carbamazepine affects the expression of ABRACL mRNA | CTD | PMID:25979313 | Abracl | Rat | carbon nanotube | increases expression | ISO | Abracl (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | Abracl | Rat | carbon nanotube | multiple interactions | ISO | ABRACL (Homo sapiens) | 6480464 | [Nanotubes and Carbon co-treated with calfactant] results in decreased expression of ABRACL protein | CTD | PMID:23026733 | Abracl | Rat | clofibrate | decreases expression | ISO | Abracl (Mus musculus) | 6480464 | Clofibrate results in decreased expression of ABRACL mRNA | CTD | PMID:23811191 | Abracl | Rat | cobalt dichloride | decreases expression | ISO | ABRACL (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of ABRACL mRNA | CTD | PMID:19320972 | Abracl | Rat | crocidolite asbestos | decreases expression | ISO | Abracl (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of ABRACL mRNA | CTD | PMID:29279043 | Abracl | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of ABRACL mRNA | CTD | PMID:26577399 | Abracl | Rat | cyclosporin A | affects expression | ISO | ABRACL (Homo sapiens) | 6480464 | Cyclosporine affects the expression of ABRACL mRNA | CTD | PMID:20106945 | Abracl | Rat | cyclosporin A | increases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ABRACL mRNA | CTD | PMID:21632981 and PMID:25562108 | Abracl | Rat | dexamethasone | multiple interactions | ISO | ABRACL (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABRACL mRNA | CTD | PMID:28628672 | Abracl | Rat | dibenzo[a,l]pyrene | decreases expression | ISO | Abracl (Mus musculus) | 6480464 | dibenzo(a and l)pyrene results in decreased expression of ABRACL mRNA | CTD | PMID:25908611 | Abracl | Rat | Dibutyl phosphate | affects expression | ISO | ABRACL (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of ABRACL mRNA | CTD | PMID:37042841 | Abracl | Rat | epoxiconazole | increases expression | ISO | Abracl (Mus musculus) | 6480464 | epoxiconazole results in increased expression of ABRACL mRNA | CTD | PMID:35436446 | Abracl | Rat | ethanol | increases expression | ISO | Abracl (Mus musculus) | 6480464 | Ethanol results in increased expression of ABRACL mRNA | CTD | PMID:30319688 | Abracl | Rat | folic acid | multiple interactions | ISO | Abracl (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABRACL mRNA | CTD | PMID:22206623 | Abracl | Rat | fulvestrant | increases methylation | ISO | ABRACL (Homo sapiens) | 6480464 | Fulvestrant results in increased methylation of ABRACL gene | CTD | PMID:31601247 | Abracl | Rat | indometacin | multiple interactions | ISO | ABRACL (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABRACL mRNA | CTD | PMID:28628672 | Abracl | Rat | ivermectin | decreases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of ABRACL protein | CTD | PMID:32959892 | Abracl | Rat | ketoconazole | decreases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Ketoconazole results in decreased expression of ABRACL mRNA | CTD | PMID:36621641 | Abracl | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of ABRACL mRNA | CTD | PMID:30047161 | Abracl | Rat | paracetamol | decreases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of ABRACL mRNA | CTD | PMID:29067470 | Abracl | Rat | quercetin | affects expression | ISO | ABRACL (Homo sapiens) | 6480464 | Quercetin affects the expression of ABRACL mRNA | CTD | PMID:21632981 | Abracl | Rat | rac-lactic acid | affects expression | ISO | ABRACL (Homo sapiens) | 6480464 | Lactic Acid affects the expression of ABRACL mRNA | CTD | PMID:30851411 | Abracl | Rat | resveratrol | multiple interactions | ISO | ABRACL (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ABRACL mRNA | CTD | PMID:23557933 | Abracl | Rat | SB 431542 | multiple interactions | ISO | ABRACL (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ABRACL protein | CTD | PMID:37664457 | Abracl | Rat | sodium arsenite | increases expression | ISO | ABRACL (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of ABRACL mRNA | CTD | PMID:28595984 more ... | Abracl | Rat | sodium arsenite | decreases expression | ISO | ABRACL (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ABRACL mRNA | CTD | PMID:29301061 | Abracl | Rat | sodium arsenite | increases expression | ISO | Abracl (Mus musculus) | 6480464 | sodium arsenite results in increased expression of ABRACL protein | CTD | PMID:29044176 | Abracl | Rat | sodium fluoride | decreases expression | ISO | Abracl (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of ABRACL protein | CTD | PMID:28918527 | Abracl | Rat | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of ABRACL mRNA | CTD | PMID:30047161 | Abracl | Rat | testosterone | decreases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Testosterone results in decreased expression of ABRACL mRNA | CTD | PMID:33359661 | Abracl | Rat | tetrachloromethane | increases expression | ISO | Abracl (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of ABRACL mRNA | CTD | PMID:27339419 and PMID:31919559 | Abracl | Rat | thiram | increases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Thiram results in increased expression of ABRACL mRNA | CTD | PMID:38568856 | Abracl | Rat | tris(2-butoxyethyl) phosphate | affects expression | ISO | ABRACL (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of ABRACL mRNA | CTD | PMID:29024780 | Abracl | Rat | tungsten | increases expression | ISO | Abracl (Mus musculus) | 6480464 | Tungsten results in increased expression of ABRACL mRNA | CTD | PMID:30912803 | Abracl | Rat | urethane | decreases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Urethane results in decreased expression of ABRACL mRNA | CTD | PMID:28818685 | Abracl | Rat | valproic acid | decreases expression | ISO | ABRACL (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ABRACL mRNA | CTD | PMID:29154799 | Abracl | Rat | valproic acid | decreases methylation | ISO | ABRACL (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of ABRACL gene | CTD | PMID:29154799 | Abracl | Rat | zearalenone | decreases expression | ISO | Abracl (Mus musculus) | 6480464 | Zearalenone results in decreased expression of ABRACL protein | CTD | PMID:36252740 | |